Delaware judge throws out largest ever patent award of $2.54bn
The Delaware jury award of $2.54 billion to Merck from 2016 has been overturned after Chief Judge Stark found the patent on a drug used to treat hepatitis C was invalid
The Delaware jury award of $2.54 billion to Merck subsidiary Idenix from 2016 – the largest ever US patent damages award – has been overturned. Gilead was granted a renewed judgment as a matter of law following a finding that...
Please log in
to read the rest of this article. New to Managing Intellectual Property?
Take advantage of free access to up to 5 articles on Managing IP and become a member today. It’s free to join and the benefits start straight away.
Please make sure you log in to read the rest of the article.
Join us nowGain FREE access to up to five free articles when you register now.